LogicMark (LGMK) Competitors $1.58 +0.02 (+1.28%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends LGMK vs. POAI, HSCS, BBLG, NAOV, AHPI, ISRG, EW, ZBH, STE, and ALGNShould you be buying LogicMark stock or one of its competitors? The main competitors of LogicMark include Predictive Oncology (POAI), Heart Test Laboratories (HSCS), Bone Biologics (BBLG), NanoVibronix (NAOV), Allied Healthcare Products (AHPI), Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), STERIS (STE), and Align Technology (ALGN). These companies are all part of the "surgical appliances & supplies" industry. LogicMark vs. Predictive Oncology Heart Test Laboratories Bone Biologics NanoVibronix Allied Healthcare Products Intuitive Surgical Edwards Lifesciences Zimmer Biomet STERIS Align Technology LogicMark (NASDAQ:LGMK) and Predictive Oncology (NASDAQ:POAI) are both small-cap industrial products companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, community ranking, risk, earnings and dividends. Do insiders & institutionals have more ownership in LGMK or POAI? 7.9% of LogicMark shares are owned by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are owned by institutional investors. 3.5% of LogicMark shares are owned by insiders. Comparatively, 3.4% of Predictive Oncology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has higher valuation & earnings, LGMK or POAI? Predictive Oncology has lower revenue, but higher earnings than LogicMark. Predictive Oncology is trading at a lower price-to-earnings ratio than LogicMark, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLogicMark$10.08M0.32-$14.55M-$223.50-0.01Predictive Oncology$1.48M3.10-$13.98M-$3.05-0.23 Does the media prefer LGMK or POAI? In the previous week, LogicMark's average media sentiment score of 0.00 equaled Predictive Oncology'saverage media sentiment score. Company Overall Sentiment LogicMark Neutral Predictive Oncology Neutral Which has more risk & volatility, LGMK or POAI? LogicMark has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500. Comparatively, Predictive Oncology has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Does the MarketBeat Community prefer LGMK or POAI? Predictive Oncology received 149 more outperform votes than LogicMark when rated by MarketBeat users. CompanyUnderperformOutperformLogicMarkN/AN/APredictive OncologyOutperform Votes14964.22% Underperform Votes8335.78% Is LGMK or POAI more profitable? LogicMark has a net margin of -141.96% compared to Predictive Oncology's net margin of -1,012.32%. LogicMark's return on equity of -124.91% beat Predictive Oncology's return on equity.Company Net Margins Return on Equity Return on Assets LogicMark-141.96% -124.91% -92.05% Predictive Oncology -1,012.32%-286.30%-122.11% Do analysts prefer LGMK or POAI? Predictive Oncology has a consensus price target of $3.00, suggesting a potential upside of 335.03%. Given Predictive Oncology's stronger consensus rating and higher possible upside, analysts clearly believe Predictive Oncology is more favorable than LogicMark.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LogicMark 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Predictive Oncology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryPredictive Oncology beats LogicMark on 8 of the 14 factors compared between the two stocks. Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Get LogicMark News Delivered to You Automatically Sign up to receive the latest news and ratings for LGMK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LGMK vs. The Competition Export to ExcelMetricLogicMarkSurgical appliances & supplies IndustryIndustrial SectorNASDAQ ExchangeMarket Cap$3.22M$9.52B$9.24B$9.08BDividend YieldN/A1.39%2.11%4.23%P/E Ratio-0.0119.5621.0817.18Price / Sales0.3232.804.86117.05Price / CashN/A22.3719.2537.85Price / Book0.015.494.224.78Net Income-$14.55M$182.72M$398.18M$225.60M7 Day Performance-6.51%-4.48%-4.86%-1.23%1 Month Performance-22.93%-5.98%-3.49%0.46%1 Year Performance-94.50%-13.75%13.98%15.24% LogicMark Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LGMKLogicMark0.8361 of 5 stars$1.58+1.3%N/A-94.9%$3.22M$10.08M-0.0126POAIPredictive Oncology2.2462 of 5 stars$0.75-3.8%$3.00+300.0%-76.7%$5M$1.48M-0.2530News CoverageGap UpHSCSHeart Test Laboratories2.2783 of 5 stars$3.87+2.7%$15.00+287.6%-75.7%$3.53M$18,600.00-0.1710Earnings ReportAnalyst ForecastNews CoverageGap UpBBLGBone Biologics0.4804 of 5 stars$1.13+0.4%N/A-68.0%$2.77MN/A0.002News CoverageNAOVNanoVibronixN/A$0.65+5.3%N/A-44.7%$2.43M$2.28M-0.5020Gap DownHigh Trading VolumeAHPIAllied Healthcare ProductsN/A$0.00+∞N/AN/A$16,000.00$27.05M0.00150News CoverageISRGIntuitive Surgical4.6145 of 5 stars$545.16+1.0%$550.28+0.9%+57.3%$194.17B$7.87B86.7513,676Analyst ForecastEWEdwards Lifesciences3.8612 of 5 stars$73.50+0.2%$79.40+8.0%-0.2%$43.35B$6.00B10.7419,800ZBHZimmer Biomet4.7397 of 5 stars$108.21+1.4%$122.83+13.5%-10.5%$21.54B$7.60B20.6818,000Dividend AnnouncementAnalyst UpgradeSTESTERIS4.9363 of 5 stars$212.97-0.6%$262.50+23.3%-5.0%$21.02B$5.14B48.9118,179Positive NewsALGNAlign Technology4.9296 of 5 stars$231.68-1.6%$271.20+17.1%-23.0%$17.30B$3.96B40.1721,610 Related Companies and Tools Related Companies POAI Competitors HSCS Competitors BBLG Competitors NAOV Competitors AHPI Competitors ISRG Competitors EW Competitors ZBH Competitors STE Competitors ALGN Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LGMK) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicMark, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicMark With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LGMK Stock Alerts